These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10555742)

  • 1. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity.
    Swartz MA; Kristensen CA; Melder RJ; Roberge S; Calautti E; Fukumura D; Jain RK
    Br J Cancer; 1999 Nov; 81(5):756-9. PubMed ID: 10555742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotransplantation of primary and established human tumour cells in nude mice.
    Noël A; Borcy V; Bracke M; Gilles C; Bernard J; Birembaut P; Mareel M; Foidart JM
    Anticancer Res; 1995; 15(1):1-7. PubMed ID: 7733618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
    Ricca A; Biroccio A; Trisciuoglio D; Cippitelli M; Zupi G; Del Bufalo D
    Br J Cancer; 2001 Dec; 85(12):1914-21. PubMed ID: 11747334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.
    Burg C; Patry Y; Le Pendu J; Moreau M; Tesson L; Godard A; Soulillou JP; Meflah K; Anegon I
    Cytokine; 1995 Nov; 7(8):784-92. PubMed ID: 8664445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of expression of a 31/33kD surface protein on human colon carcinoma cells is a marker for metastasizing potential.
    Puhlmann CM; Freiberg B; Anderer FA
    Anticancer Res; 1994; 14(6B):2701-7. PubMed ID: 7872705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a model of colon cancer progression.
    Hewitt RE; McMarlin A; Kleiner D; Wersto R; Martin P; Tsokos M; Stamp GW; Stetler-Stevenson WG
    J Pathol; 2000 Dec; 192(4):446-54. PubMed ID: 11113861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
    Paulsen JE; Elgjo K
    In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line.
    López-Conejo T; Olmo N; Turnay J; Navarro J; Lizarbe A
    Int J Cancer; 1996 Sep; 67(5):668-75. PubMed ID: 8782656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy.
    Trotter GA; Morgan GR; Cooper AJ; Kirkham N; Whitehouse JM; Taylor I
    Gut; 1985 Mar; 26(3):267-73. PubMed ID: 3972273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
    Staley CA; Parikh NU; Gallick GE
    Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further biologic characteristics of a human carcinoembryonic antigen-producing colon carcinoma cell line.
    Drewinko B; Yang LY; Barlogie B; Romsdahl M; Meistrich M; Malahy MA; Giovanella B
    J Natl Cancer Inst; 1978 Jul; 61(1):75-83. PubMed ID: 276641
    [No Abstract]   [Full Text] [Related]  

  • 12. N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells.
    Dexter DL; Barbosa JA; Calabresi P
    Cancer Res; 1979 Mar; 39(3):1020-5. PubMed ID: 427742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single injection of immature dendritic cells is able to induce antitumour response against a murine colon adenocarcinoma with a low apoptotic index.
    Jalili A; Stoklosa T; Giermasz A; Olszewska D; Wilczynski G; Jakobisiak M; Golab J
    Oncol Rep; 2002; 9(5):991-4. PubMed ID: 12168061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of seven clones of the WiDr human colon adenocarcinoma cell line.
    Petricciani JC; Smith P; Earley EM; Levenbook I; Noguchi P
    In Vitro; 1982 May; 18(5):492-4. PubMed ID: 7118132
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined electric field and ultrasound therapy as a novel anti-tumour treatment.
    Larkin J; Soden D; Collins C; Tangney M; Preston JM; Russell LJ; McHale AP; Dunne C; O'Sullivan GC
    Eur J Cancer; 2005 Jun; 41(9):1339-48. PubMed ID: 15913991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immortality, clonogenicity, tumorigenicity and the metastatic phenotype.
    Price JE; Syms AJ; Wallace JS; Fleming KA; Tarin D
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):349-55. PubMed ID: 3709603
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue.
    Chen CC; Lin WC; Kong MS; Shi HN; Walker WA; Lin CY; Huang CT; Lin YC; Jung SM; Lin TY
    Br J Nutr; 2012 Jun; 107(11):1623-34. PubMed ID: 21992995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-isolated human tumor xenografts in athymic nude mice.
    Kristjansen PE; Roberge S; Lee I; Jain RK
    Microvasc Res; 1994 Nov; 48(3):389-402. PubMed ID: 7731400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human colon tumor growth in nude mice by indomethacin.
    Heneghan JB
    Prog Clin Biol Res; 1985; 181():315-8. PubMed ID: 3161089
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
    Cullis ER; Kalber TL; Ashton SE; Cartwright JE; Griffiths JR; Ryan AJ; Robinson SP
    Microvasc Res; 2006 Mar; 71(2):76-84. PubMed ID: 16530791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.